Floatz logo

FLUMAZENIL

Electroconvulsive Therapy

Anders JørgensenSmall moleculeN/AActive
D
30/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
15/ 100
Competitive Position
95/ 100

Competitive context

1 Active assets in the Electroconvulsive Therapy cohort.

Asset / SponsorPhaseRating
(±)-2-(O-CHLOROPHENYL)-2-(METHYLAMINO)CYCLOHEXANONE
Tanta University
Phase 4BB
Sevoflurane
Inonu University
Phase 4BB
Nimodipine
Rijnstate Hospital
Phase 2B

Same molecule, other indications

FLUMAZENIL is also rated in:

Parkinson diseaseDormant
CCC
Indicative ·
48 / 100
View asset →
hepatic encephalopathyDormant
CC
Indicative ·
45 / 100
View asset →
cirrhosis of liverDormant
CC
Indicative ·
43 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →